Acute effect of sidestream cigarette smoke extract on vascular endothelial function

Journal of Cardiovascular Pharmacology

Volumn 52, Issue 3, 2008, Pages 262-267

  Argacha, J F ^a   Fontaine, D ^b   Adamopoulos, D ^a   Ajose, A ^b   Van Borne, P D ^a   Fontaine, J ^b   Berkenboom, G ^a  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Aorta; Endothelium; Nicotine; Passive smoking; Rats

Indexed keywords

ACETYLCHOLINE; CIGARETTE SMOKE; NICOTINE; PHENYLEPHRINE; SUPEROXIDE; VASODILATOR AGENT;

ANIMAL TISSUE; AORTA WALL; ARTERY DILATATION; ARTICLE; BLOOD VESSEL FUNCTION; BLOOD VESSEL WALL; CONCENTRATION RESPONSE; CONTROLLED STUDY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM; ANIMAL; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; METABOLISM; PASSIVE SMOKING; PATHOPHYSIOLOGY; SMOKE; THORACIC AORTA; TOBACCO; VASODILATATION; WISTAR RAT;

ACETYLCHOLINE; ANIMALS; AORTA, THORACIC; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; MALE; NICOTINE; OXIDATIVE STRESS; RATS; RATS, WISTAR; SMOKE; SUPEROXIDES; TOBACCO; TOBACCO SMOKE POLLUTION; VASODILATION; VASODILATOR AGENTS;

EID: 58149267994     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e318185fa26     Document Type: Article

References (39)

1. Wells AJ. Passive smoking as a cause of heart disease. J Am Coll Cardiol. 1994;24:546-554.
2. Kawachi I, Colditz GA, Speizer FE, et al. A prospective study of passive smoking and coronary heart disease. Circulation. 1997;95:2374-2379.
3. American Non-Smokers' Rights Foundation. Summary of United States Population Protected by 100% Smokefree Laws, 2007. Available at: www.no-smoke.org; Accessed: July 18, 2008.
4. Raupach T, Schafer K, Konstantinides S, et al. Secondhand smoke as an acute threat for the cardiovascular system: a change in paradigm. Eur Heart J. 2006;27:386-392.
5. Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation. 2005;111:2684-2698.
6. Argacha JF, Adamopoulos D, Gujic M, et al. Acute effects of passive smoking on peripheral vascular function. Hypertension. 2008;51:1506-1511
7. Argacha JF, Xhaet O, Gujic M, et al. Nicotine increases chemoreflex sensitivity to hypoxia in non-smokers. J Hypertens. 2008;26:284-294.
8. Najem B, Houssiere A, Pathak A, et al. Acute cardiovascular and sympathetic effects of nicotine replacement therapy, Hypertension. 2006; 47:1162-1167.
9. Adamopoulos D, van de Borne P, Argacha JF. New insights into the sympathetic, endothelial and coronary effects of nicotine. Clin Exp Pharmacol Physiol 2008;35:458-463.
10. Jaimes EA, DeMaster EG, Tian RX, et al. Stable compounds of cigarette smoke induce endothelial superoxide anion production via NADPH oxidase activation. Arterioscler Thromb Vasc Biol. 2008;24:1031-1036.
11. Mayhan WG, Sharpe GM. Effect of cigarette smoke extract on arteriolar dilatation in vivo. J Appl Physiol. 1996;81:1996-2003.
12. Murohara T, Kugiyama K, Ohgushi M, et al. Cigarette smoke extract contracts isolated porcine coronary arteries by superoxide anion-mediated degradation of EDRF. Am J Physiol. 1994;266:H874-H880.
13. Ota Y, Kugiyama K, Sugiyama S, et al. Impairment of endothelium-dependent relaxation of rabbit aortas by cigarette smoke extract-role of free radicals and attenuation by captopril. Atherosclerosis. 1997;131:195- 202.
14. Su Y, Han W, Giraldo C, et al. Effect of cigarette smoke extract on nitric oxide synthase in pulmonary artery endothelial cells. Am J Respir Cell Mol Biol. 1998;19:819-825.
15. Zhang WZ, Venardos K, Chin-Dusting J, et al. Adverse effects of cigarette smoke on NO bioavailability: role of arginine metabolism and oxidative stress. Hypertension. 2006;48:278-285.
16. Nurkiewicz TR, Porter DW, Barger M, et al. Particulate matter exposure impairs systemic microvascular endothelium-dependent dilation. Environ Health Perspect. 2004;112:1299-1306.
17. Fontaine D, Fontaine J, Dupont I, et al. Chronic hydroxymethylglutaryl coenzyme a reductase inhibition and endothelial function of the normocholesterolemic rat: comparison with angiotensin-converting enzyme inhibition. J Cardiovasc Pharmacol. 2002;40:172-180.
18. Schick S, Glantz S. Scientific analysis of second-hand smoke by the tobacco industry, 1929-1972. Nicotine Tob Res. 2005;7:591-612.
19. Rickert WS, Robinson JC, Collishaw N. Yields of tar, nicotine, and carbon monoxide in the sidestream smoke from 15 brands of Canadian cigarettes. Am J Public Health. 1984;74:228-231.
20. Bruggmann D, Lips KS, Pfeil U, et al. Multiple nicotinic acetylcholine receptor alpha-subunits are expressed in the arterial system of the rat. Histochem Cell Biol. 2005;118:441-447.
21. Li Z, Duckles SP. Acute effects of nicotine on rat mesenteric vasculature and tail artery. J Pharmacol Exp Ther. 1993;2264:1305-1310.
22. Levy JV. Prostacyclin-induced contraction of isolated aortic strips from normal and spontaneously hypertensive rats (SHR). Prostaglandins. 1980;19:517-525.
23. Shimokawa H, Matoba T. Hydrogen peroxide as an endothelium-derived hyperpolarizing factor. Pharmacol Res. 2004;49:543-549.
24. Vann RE, James JR, Rosecrans JA, et al. Nicotinic receptor inactivation after acute and repeated in vivo nicotine exposures in rats. Brain Res. 2006;1086:98-103.
25. Miller VM, Clouse WD, Tonnessen BH, et al. Time and dose effect of transdermal nicotine on endothelial function. Am J Physiol Heart Circ Physiol. 2000;279:H1913-H1921.
26. Waldum HL, Nilsen OG, Nilsen T, et al. Long-term effects of inhaled nicotine. Life Sci. 1996;58:1339-1346.
27. Luo HL, Zang WJ, Lu J, et al. The protective effect of captopril on nicotine-induced endothelial dysfunction in rat. Basic Clin Pharmacol Toxicol. 2006;99:237-245.
28. Yuan BX, Hou J, He LC, et al. Evaluation of drug-muscarinic receptor affinities using cell membrane chromatography and radioligand binding assay in guinea pig jejunum membrane. Acta Pharmacol Sin. 2005;26: 113-116.
29. Roemer E, Stabbert R, Rustemeier K, et al. Chemical composition, cytotoxicity and mutagenicity of smoke from US commercial and reference cigarettes smoked under two sets of machine smoking conditions. T oxicology. 2004;195:31-52.
30. Fujioka K, Shibamoto T. Determination of toxic carbonyl compounds in cigarette smoke. Environ Toxicol. 2006;21:47-54.
31. Schick S, Glantz S. Philip Morris toxicological experiments with fresh sidestream smoke: more toxic than mainstream smoke. Tob Control. 2005; 14:396-404.
32. Talbot P, DiCarlantonio G, Knoll M, et al. Identification of cigarette smoke components that alter functioning of hamster (Mesocricetus auratus) oviducts in vitro. Biol Reprod. 1998;58:1047-1053.
33. Patel JM, Block ER. Acrolein-induced injury to cultured pulmonary artery endothelial cells. Toxicol Appl Pharmacol. 1993;122:46-53.
34. Hong SP, Jeong MG, Lim DY. Effect of anabasine on catecholamine secretion from the perfused rat adrenal medulla. J Cardiol. 2007;50:351- 362.
35. Hausberg M, Mark AL, Winniford MD, et al Sympathetic and vascular effects of short-term passive smoke exposure in healthy nonsmokers. Circulation. 1997;96:282-287.
36. Otsuka R, Watanabe H, Hirata K, et al. Acute effects of passive smoking on the coronary circulation in healthy young adults. JAMA. 2001;286: 436-441.
37. Schmid P, Karanikas G, Kritz H, et al. Passive smoking and platelet thromboxane. Thromb Res. 1996;81:451-460.
38. Cesaroni G, Forastiere F, Agabiti N, et al. Effect of the Italian smoking ban on population rates of acute coronary events. Circulation. 2008;1117: 1183-1188.
39. Nilsson R. Environmental tobacco smoke revisited: the reliability of the data used for risk assessment. Risk Anal. 2001;21:737-760.